EMN - Eastman Chemical Company
NYSE
->
Basic Materials
->
Chemicals
Kingsport,
United States
Type: Equity
EMN price evolution
EMN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $514 | $499 | $548 | |
| Short term investments | ||||
| Net receivables | $1332 | $1329 | $1274 | $1154 |
| Inventory | $1904 | $1900 | $1769 | $1683 |
| Total current assets | $3937 | $3842 | $3638 | $3481 |
| Long term investments | ||||
| Property, plant & equipment | $5589 | $5529 | $5535 | $5548 |
| Goodwill & intangible assets | $4727 | $4754 | $4784 | |
| Total noncurrent assets | $11103 | $11110 | $11152 | |
| Total investments | ||||
| Total assets | $15060 | $14945 | $14748 | $14633 |
| Current liabilities | ||||
| Accounts payable | $2142 | $2044 | $1878 | $2035 |
| Deferred revenue | ||||
| Short long term debt | $697 | $740 | $541 | |
| Total current liabilities | $2590 | $2741 | $2618 | $2576 |
| Long term debt | $4606 | $4336 | $4340 | $4305 |
| Total noncurrent liabilities | $6505 | $6522 | $6527 | |
| Total debt | $5033 | $5080 | $4846 | |
| Total liabilities | $9406 | $9246 | $9140 | $9103 |
| Shareholders' equity | ||||
| Retained earnings | $9780 | $9694 | $9559 | $9490 |
| Other shareholder equity | -$277 | -$302 | -$328 | -$319 |
| Total shareholder equity | $5627 | $5538 | $5458 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $548 | $493 | $459 | $564 |
| Short term investments | ||||
| Net receivables | $1154 | $1277 | $1580 | $1515 |
| Inventory | $1683 | $1894 | $1504 | $1379 |
| Total current assets | $3481 | $3778 | $4646 | $3541 |
| Long term investments | $156 | |||
| Property, plant & equipment | $5548 | $5371 | $4996 | $5549 |
| Goodwill & intangible assets | $4784 | $4874 | $5003 | $6257 |
| Total noncurrent assets | $11152 | $10889 | $10873 | $12542 |
| Total investments | ||||
| Total assets | $14633 | $14667 | $15519 | $16083 |
| Current liabilities | ||||
| Accounts payable | $2035 | $1319 | $2133 | $1689 |
| Deferred revenue | ||||
| Short long term debt | $541 | $1126 | $747 | $349 |
| Total current liabilities | $2576 | $3251 | $2971 | $2038 |
| Long term debt | $4305 | $4025 | $4412 | $5269 |
| Total noncurrent liabilities | $6527 | $6180 | $6760 | $7937 |
| Total debt | $4846 | $5151 | $5159 | $5618 |
| Total liabilities | $9103 | $9514 | $9731 | $9975 |
| Shareholders' equity | ||||
| Retained earnings | $9490 | $8973 | $8557 | $8080 |
| Other shareholder equity | -$319 | -$204 | -$182 | -$273 |
| Total shareholder equity | $5458 | $5153 | $5704 | $6023 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2464 | $2363 | $2310 | $2207 |
| Cost of revenue | $1764 | $1778 | ||
| Gross Profit | $605 | $599 | $532 | $464 |
| Operating activities | ||||
| Research & development | $60 | $59 | ||
| Selling, general & administrative | $180 | $191 | ||
| Total operating expenses | $246 | $236 | $256 | $295 |
| Operating income | $363 | $276 | ||
| Income from continuing operations | ||||
| EBIT | $336 | $263 | ||
| Income tax expense | $99 | $56 | $49 | $114 |
| Interest expense | -$49 | $50 | $49 | -$52 |
| Net income | ||||
| Net income | $180 | $230 | $165 | $310 |
| Income (for common shares) | $230 | $165 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9210 | $10580 | $8473 | |
| Cost of revenue | $8443 | $6498 | ||
| Gross Profit | $2061 | $2137 | $1975 | |
| Operating activities | ||||
| Research & development | $264 | $226 | ||
| Selling, general & administrative | $726 | $654 | ||
| Total operating expenses | $1045 | $941 | $1226 | |
| Operating income | $1196 | $749 | ||
| Income from continuing operations | ||||
| EBIT | $1156 | $729 | ||
| Income tax expense | $191 | $181 | $41 | |
| Interest expense | -$215 | $182 | $210 | |
| Net income | ||||
| Net income | $894 | $793 | $478 | |
| Income (for common shares) | $793 | $478 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $230 | $165 | ||
| Operating activities | ||||
| Depreciation | $126 | $127 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $367 | -$16 | ||
| Investing activities | ||||
| Capital expenditures | -$117 | -$186 | ||
| Investments | ||||
| Total cash flows from investing | -$402 | -$121 | -$179 | -$432 |
| Financing activities | ||||
| Dividends paid | -$285 | -$95 | -$95 | -$376 |
| Sale and purchase of stock | -$100 | |||
| Net borrowings | -$43 | $244 | ||
| Total cash flows from financing | -$273 | -$227 | $148 | -$888 |
| Effect of exchange rate | $2 | -$4 | -$2 | $1 |
| Change in cash and equivalents | $74 | $15 | -$49 | $55 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $793 | $857 | $478 | |
| Operating activities | ||||
| Depreciation | $477 | $538 | $574 | |
| Business acquisitions & disposals | $997 | $553 | -$1 | |
| Stock-based compensation | ||||
| Total cash flows from operations | $975 | $1619 | $1455 | |
| Investing activities | ||||
| Capital expenditures | -$624 | -$578 | -$383 | |
| Investments | ||||
| Total cash flows from investing | -$432 | $392 | -$29 | -$394 |
| Financing activities | ||||
| Dividends paid | -$376 | -$381 | -$375 | -$358 |
| Sale and purchase of stock | -$1002 | -$1000 | -$60 | |
| Net borrowings | $76 | -$350 | -$307 | |
| Total cash flows from financing | -$888 | -$1321 | -$1690 | -$704 |
| Effect of exchange rate | $1 | -$12 | -$5 | $3 |
| Change in cash and equivalents | $55 | $34 | -$105 | $360 |
News
Fundamentals
| Market cap | $12.26B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 115.86M |
| Revenue | $9.34B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $885.00M |
| Revenue Q/Q | 8.69% |
| Revenue Y/Y | -0.34% |
| P/E ratio | 13.86 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.31 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $7.64 |
|---|---|
| ROA | 5.96% |
| ROE | N/A |
| Debt/Equity | 1.67 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.52 |
| Quick ratio | 0.78 |